Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

anticoagulants, U.S. market, Technavio, 2020, trends
News | Antiplatelet and Anticoagulation Therapies | May 25, 2016

May 25, 2016 — Technavio’s latest report on the U.S....

Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell

Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...

News | Atrial Fibrillation | May 19, 2016

May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a...

St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab | May 19, 2016

May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR...

News | Ablation Systems | May 11, 2016

May 11, 2016 — Patients with Wolff-Parkinson-White syndrome who receive...

News | Pacemakers | May 09, 2016

May 9, 2016 — Results from a first-of-its-kind study identify a significant increase in the incidence of...

warfarin, atrial fibrillation, dementia, Intermountain Healthcare Study, HRS 2016
News | Antiplatelet and Anticoagulation Therapies | May 09, 2016

May 9, 2016 — A new study has found an increased risk of dementia in patients with...

atrial fibrillation risk, heart failure, African Americans, Hispanics, whites, HRS 2016
News | Atrial Fibrillation | May 09, 2016

May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among...

AtriCure, AtriClip PRO2 LAA Exclusion System, left atrial appendage, FDA clearance
Technology | Left Atrial Appendage (LAA) Occluders | April 29, 2016

April 29, 2016 — AtriCure Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip...

post-operative atrial fibrillation, AFib, heart rate, rhythm control, ACC.16
News | Atrial Fibrillation | April 20, 2016

April 20, 2016 — In the first large randomized trial to directly compare two approaches to preventing...

Videos | Left Atrial Appendage (LAA) Occluders | April 15, 2016

David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal...

Xarelto, rivaroxaban, PMSS study, ACC 2016, NVAF, atrial fibrillation, stroke
News | Antiplatelet and Anticoagulation Therapies | April 08, 2016

April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban)...

Overlay Init